This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: I-Sep. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Patricia Forest-Villegas
Introduction
Patricia Forest-Villegas is a notable inventor based in Genas, France. She has made significant contributions to the field of medical technology, particularly in the area of autotransfusion. With a total of 3 patents to her name, her work focuses on improving patient outcomes through innovative solutions.
Latest Patents
One of her latest patents is a system and method for treating haemorrhagic fluid for autotransfusion. This invention involves a method and system for filtering haemorrhagic fluid contained in a container, aiming to concentrate red blood cells to reach a target haematocrit level. The process also removes unwanted compounds from the fluid, ensuring its suitability for autotransfusion. Another related patent further elaborates on the treatment unit designed for processing haemorrhagic fluid previously taken from a patient, enhancing the efficiency of autotransfusion procedures.
Career Highlights
Patricia is currently associated with I-Sep, a company dedicated to advancing medical technologies. Her work at I-Sep has positioned her as a key player in the development of innovative solutions for blood management and transfusion processes.
Collaborations
Throughout her career, Patricia has collaborated with notable professionals in her field, including Francis Gadrat and Stéphane Chollet. These partnerships have contributed to the advancement of her inventions and the overall impact of her work in medical technology.
Conclusion
Patricia Forest-Villegas exemplifies the spirit of innovation in the medical field. Her patents and contributions are paving the way for improved autotransfusion methods, ultimately enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile